Research funded by the National Institute for Health and Care Research (NIHR) has shown that higher levels of inflammation in the blood of patients with obesity undergoing bariatric surgery predicts poorer weight loss six months after the procedure.
FDA approves X4 Pharmaceuticals’ pill for ultra-rare immunodeficiency disease
X4 Pharmaceuticals announced Monday morning that the FDA approved its daily pill for WHIM syndrome — an ultra-rare immune disease named after its symptoms. The
April 30, 2024